Nosebleed: causes and therapy
Petruson, B.
Medizinische Monatsschrift für Pharmazeuten 7(3): 70-75
1984
ISSN/ISBN: 0342-9601 PMID: 6708918 Document Number: 227747
Document emailed within 1 workday
Related Documents
Kretschmann, F. 2004: Nosebleed and its treatment Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 98(4): 309-311Nordbladh, G. 1994: Is there a suitable agent against nosebleed? Lakartidningen 91(12): 1172
Wlazłowski, M.; Płoszyńska, A. 1986: A case of hypoproconvertinemia in a boy with recurrent nosebleed Polski Tygodnik Lekarski 41(37): 1186-1187
Shuster, M.A.; Rogachikova, T.A.; Iausheva, A.A.; Ageeva, S.A. 1983: Surgical treatment of patients with prolonged traumatic nosebleed Vestnik Otorinolaringologii 5: 58-62
Yu, H-xin.; Liu, G. 2011: Report of a case with hemophilia B complicated with traumatic nosebleed as the first symptom Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 46(7): 589
Seifert, R.; Hülse, M. 1983: Clinical experience with blood vessel ligation in uncontrollable nosebleed Hno 31(5): 177-179
Dunaĭvitser, B.I.; Grigorian, M.A. 1981: Recurrent nosebleed caused by traumatic rupture of the internal carotid artery Vestnik Otorinolaringologii 1: 67-68
Hazin, R.; Dixon, J.A.; Bhatti, M.T. 2009: Thrombolytic therapy in central retinal artery occlusion: cutting edge therapy, standard of care therapy, or impractical therapy? Current Opinion in Ophthalmology 20(3): 210-218
Tani, M.; Yamaue, H. 2012: Multidisciplinary therapy for pancreatic cancer - clinical impact for preoperative therapy and peptide vaccine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(3): 364-367
Kitamura, T.; Maruyama, T.; Nakamura, H.; Hayashi, K.; Shigehira, M.; Iwaki, Y.; Okamoto, T.; Ishikawa, T.; Ishinoda, Y.; Kisanuki, H. 1990: Therapy of hepatocellular carcinoma with UFT--clinical evaluation of its effect in the combination therapy with transcatheter arterial embolization or one shot therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(8 Part 1): 1467-1471
1983: Pathogenesis, diagnosis and therapy of ulcer diseases. 6. Therapy. Pharmacologic principles and antacid therapy Die Medizinische Welt 34(47): 14-18
Soma, I.; Hasuike, Y.; Hayashi, N.; Fukuchi, N.; Izawa, H.; Yoshida, T.; Ebisui, C.; Sakita, I.; Fujimoto, T.; Koshino, T.; Izumiyama, K. 2004: A case report--Efficacy of combination therapy to unresectable advanced gall bladder carcinoma--palliative operation, hepatic arterial infusion therapy, and radiation therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(11): 1903-1905
Aminian, K.; Farsad, F.; Ghanbari, A.; Fakhreih, S.; Hasheminasab, S.M. 2010: A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 31(4): 303-307
Li, J.-m.; Yu, J.-m.; Liu, S.-w.; Chen, Q.; Mu, X.-k.; Jiang, Q.-a.; Zhao, M.-h.; Zhang, J.-g. 2009: Dose distributions of proton beam therapy for hepatocellular carcinoma: a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy Zhonghua Yi Xue Za Zhi 89(45): 3201-3206
Shin, S.; Muñoz, M.; Zeladita, J.; Slavin, S.; Caldas, A.; Sanchez, E.; Callacna, M.; Rojas, C.; Arevalo, J.; Sebastian, J.L.; Bayona, J. 2011: How does directly observed therapy work? the mechanisms and impact of a comprehensive directly observed therapy intervention of highly active antiretroviral therapy in Peru Health and Social Care in the Community 19(3): 261-271
Ramsay, D.L. 1995: Position paper: use of occupational therapy aides in occupational therapy practice. American Occupational Therapy Association American journal of occupational therapy: official publication of the American Occupational Therapy Association 49(10): 1023-1025
Federico, M.; Clò, V.; Carella, A.M. 1996: High-dose therapy autologous stem cell transplantation vs conventional therapy for patients with advanced Hodgkin's disease responding to first-line therapy: analysis of clinical characteristics of 51 patients enrolled in the HD01 protocol. EBMT/ANZLG/Intergroup HD01 Trial Leukemia 10 Suppl. 2: S69-S71
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Gray, D.M.; Workman, L.J.; Lombard, C.J.; Jennings, T.; Innes, S.; Grobbelaar, C.J.; Cotton, M.F.; Zar, H.J. 2014: Isoniazid preventive therapy in HIV-infected children on antiretroviral therapy: a pilot study International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 18(3): 322-327